Method: LC-MS/MS (Liquid Chromatography/Tandem Mass Spectrometry) with creatinine normalization by Jaffe Reaction (CLIA 17D0919496); not cleared or approved by the FDA. Results reported in µg/g creatinine. Not a stand-alone diagnosis; should be interpreted in clinical context.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Monoisobutyl phthalate (MiBP) testing
- Di-isobutyl phthalate exposure tracking
- adhesive and personal care product chemical monitoring
What is Monoisobutyl phthalate (MiBP)?
MiBP is the primary urinary metabolite of di-isobutyl phthalate (DiBP), a plasticizer found in adhesives, sealants, and personal care products. Measured via LC-MS/MS with creatinine normalization.
Why is Monoisobutyl phthalate (MiBP) important?
DiBP shares structural and potential biological similarities with DBP-type phthalates. MiBP is commonly detected in population studies and may reflect both dietary and non-dietary exposure routes.
What insights will I get?
Your MiBP level may reflect DiBP exposure from adhesives, food contact materials, or personal care items. Tracking over time may reveal patterns tied to specific products or environments.





.avif)
.avif)

